Multidisciplinary approach to patients with heart failure and kidney disease: preliminary experience of an integrated cardiorenal unit

Author:

Marques María12ORCID,Cobo Marta34ORCID,López-Sánchez Paula1ORCID,García-Magallón Belén3,Salazar María Luisa Serrano15ORCID,López-Ibor Jorge V3ORCID,Janeiro Darío15,García Estefanya15,Briales Paula Sánchez1,Montero Esther6,Illazquez María Victoria López1,Gómez Teresa Soria3,Citores Yolanda Martínez6,Peral Ana Martínez1,Segovia Javier32,Portolés José125ORCID

Affiliation:

1. Nephrology Department, Hospital Puerta de Hierro Majadahonda , IDIPHISA, Madrid , Spain

2. Medicine Department, Facultad de Medicina, Universidad Autónoma Madrid , Madrid , Spain

3. Cardiology Department, Hospital Puerta de Hierro Majadahonda , IDIPHISA, Madrid , Spain

4. Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV) , Madrid , Spain

5. RETIC ISCIII REDinREN 16/009/009

6. Internal Medicine Department, Hospital Puerta de Hierro Majadahonda , IDIPHISA, Madrid , Spain

Abstract

ABSTRACT Background Cardiorenal programs have emerged to improve the management of cardiorenal disease (CRD). Evidence about the benefits of these programs is still scarce. This work aims to evaluate the performance of a novel cardiorenal program and describe the clinical profile and outcomes of patients with CRD. Methods We conducted a retrospective observational study of patients with CRD attended in a cardiorenal unit (CRU) from February 2021 to February 2022. Demographics and laboratory tests were collected and events (all-cause death and cardiovascular hospitalizations) were evaluated. Optimization of comorbidities and protective therapies was also assessed. Results Eighty-two patients were included, with a mean age of 76.8 years [standard deviation (SD) 8.5] and 72% were men. A total of 58.5% (n = 47) had left ventricular ejection fraction <50%. The mean follow-up was 11 months (SD 4.0). Almost 54% of the patients (n = 44) required hospitalization, 30.5% for heart failure (HF) decompensation. Total hospitalizations significantly decreased after CRU inclusion: 0.70 versus 0.45 admissions/year (P < .02). Global mortality was 17.1% (n = 14). The percentage of patients with HF with reduced ejection fraction on quadruple therapy increased by 20%, and up to 60% of the patients were on three drugs. A total of 39% of the patients with HF and preserved ejection fraction started treatment with sodium–glucose co-transporter inhibitors. Hyperkalaemia required the use of potassium binders in 12.2% of the patients and treatment of secondary hyperparathyroidism was started in 42.7% and renal anaemia in 23.2%. Renal replacement therapy was initiated in 10% of the patients (n = 8). Conclusion CRD confers a considerable risk of adverse outcomes. Cardiorenal programs may improve cardiorenal syndrome management by optimizing therapies, treating comorbidities and reducing hospitalizations.

Funder

Hospital Puerta de Hierro Majadahonda Research Institute

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3